SciSparc Ltd. (SPRC) SEC filings

SPRCNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 29, 2026Score 3/30

$0.36−0.04 (-10.77%)

Close on Nov 12, 2026Market cap $129.84KP/E 0.0Yield –

SEC filings

40 of SciSparc's most recent filings on SEC EDGAR

Document	Form	Period	Filed	Source
Current report	6-K	Nov 3, 2026	Nov 3, 2026	SEC EDGAR
Current report	6-K	Oct 26, 2026	Oct 26, 2026	SEC EDGAR
Current report	6-K	Oct 23, 2026	Oct 23, 2026	SEC EDGAR
Current report	6-K	Oct 15, 2026	Oct 15, 2026	SEC EDGAR
Current report	6-K	Oct 15, 2026	Oct 15, 2026	SEC EDGAR
Current report	6-K	Oct 7, 2026	Oct 7, 2026	SEC EDGAR
Current report	6-K	Jun 30, 2026	Sep 30, 2026	SEC EDGAR
Current report	6-K	Sep 24, 2026	Sep 24, 2026	SEC EDGAR
Current report	6-K	Sep 2, 2026	Sep 2, 2026	SEC EDGAR
Current report	6-K	Aug 26, 2026	Aug 26, 2026	SEC EDGAR
Current report	6-K	Aug 24, 2026	Aug 24, 2026	SEC EDGAR
Annual report, amended	20-F/A	Dec 31, 2025	Aug 19, 2026	SEC EDGAR
Current report	6-K	Aug 18, 2026	Aug 18, 2026	SEC EDGAR
Current report	6-K	Aug 12, 2026	Aug 12, 2026	SEC EDGAR
Current report	6-K	Aug 5, 2026	Aug 5, 2026	SEC EDGAR
Current report	6-K	Jul 31, 2026	Jul 31, 2026	SEC EDGAR
Current report	6-K	Jul 29, 2026	Jul 29, 2026	SEC EDGAR
Current report	6-K	Jul 15, 2026	Jul 15, 2026	SEC EDGAR
Current report	6-K	Jun 4, 2026	Jun 4, 2026	SEC EDGAR
Current report	6-K	May 29, 2026	May 29, 2026	SEC EDGAR
Current report	6-K	May 11, 2026	May 11, 2026	SEC EDGAR
Annual report	20-F	Dec 31, 2025	Apr 29, 2026	SEC EDGAR
Current report	6-K	Mar 16, 2026	Mar 16, 2026	SEC EDGAR
Current report	6-K	Mar 12, 2026	Mar 12, 2026	SEC EDGAR
Current report	6-K	Mar 2, 2026	Mar 2, 2026	SEC EDGAR
Current report	6-K	Feb 17, 2026	Feb 17, 2026	SEC EDGAR
Current report	6-K	Feb 12, 2026	Feb 12, 2026	SEC EDGAR
Current report	6-K	Feb 4, 2026	Feb 4, 2026	SEC EDGAR
Current report	6-K	Feb 2, 2026	Feb 2, 2026	SEC EDGAR
Current report	6-K	Jan 26, 2026	Jan 26, 2026	SEC EDGAR
Current report	6-K	Jan 13, 2026	Jan 13, 2026	SEC EDGAR
Current report	6-K	Jan 13, 2026	Jan 13, 2026	SEC EDGAR
Current report	6-K	Jan 12, 2026	Jan 12, 2026	SEC EDGAR
Current report	6-K	Dec 9, 2025	Dec 31, 2025	SEC EDGAR
Current report	6-K	Dec 2, 2025	Dec 2, 2025	SEC EDGAR
Current report	6-K	Nov 28, 2025	Nov 28, 2025	SEC EDGAR
Current report	6-K	Nov 26, 2025	Nov 26, 2025	SEC EDGAR
Current report	6-K	Nov 20, 2025	Nov 20, 2025	SEC EDGAR
Current report	6-K	Jun 30, 2025	Nov 18, 2025	SEC EDGAR
Current report	6-K	Oct 27, 2025	Oct 27, 2025	SEC EDGAR

Where these numbers come from

Parsed from the XBRL in SciSparc's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-9 reverse split on Mar 4, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is SPRC.

Compare: SPRC vs XTLB · SPRC vs RFL · SPRC vs SPRB · SPRC vs CANF · SPRC vs MNOV

Operating margin-978.3% · median -2527.4%

Net margin-1422.8% · median -2258.9%

Company	Revenue	Growth
MNOV	$935.72K	–
RFL	$874.00K	-4.7%
SPRC	$856.00K	-34.5%
XTLB	–	–
SPRB	–	–
CANF	–	–

Company

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
Fiscal year ends: December 31
Employees: 3
Held by institutions: 0.0%
Auditor: Brightman Almagor Zohar & Co.
SEC CIK: 1611746

Advertisement
300 × 250

See a number that looks wrong?